Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter MV 2mg/500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimter MV 2mg/500mg/0.3mg Tablet SR

Glimter MV 2mg/500mg/0.3mg extended-release tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's part of a comprehensive diabetes management plan that includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are critical in diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before initiating treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended by your healthcare provider.

Uses of Glimter MV 2mg/500mg/0.3mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimter MV 2mg/500mg/0.3mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Glimter MV 2mg/500mg/0.3mg Extended-Release Tablet on an empty stomach.

Common Side effects of Glimter MV 2mg/500mg/0.3mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimter MV 2mg/500mg/0.3mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Glimter MV 2mg/500mg/0.3mg Extended-Release Tablet on an empty stomach.

How Glimter MV 2mg/500mg/0.3mg Tablet SR works:

Glimter MV SR tablets (2mg/500mg/0.3mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimter MV 2mg/500mg/0.3mg SR Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimter MV 2mg/500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glimter MV 2mg/500mg/0.3mg tablet is likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The extended-release Glimter MV 2mg/500mg/0.3mg tablet is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimter MV 2mg/500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Glimter MV 2mg/500mg/0.3mg SR tablets is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimter MV 2mg/500mg/0.3mg Tablet SR :

Should you forget a dose of Glimter MV 2mg/500mg/0.3mg SR Tablet, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimter MV 2mg/500mg/0.3mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Glimter MV 2mg/500mg/0.3mg Tablet SR

Glimter MV 2mg/500mg/0.3mg Extended-Release Tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when coupled with a suitable diet and physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, decreases postprandial hyperglycemia. This formulation is unsuitable for type 1 diabetes treatment.
Glimter MV 2mg/500mg/0.3mg sustained-release tablets may cause common adverse events including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to any Glimter MV 2mg/500mg/0.3mg Tablet SR ingredient or additive should not take this medication. This medicine is contraindicated for individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Glimter MV 2mg/500mg/0.3mg SR tablets is inadvisable. This combination may lead to dangerously low blood glucose (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glimter MV 2mg/500mg/0.3mg Tablet SR can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Maintain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Glimter MV 2mg/500mg/0.3m...
111
MRP 135
17% off